Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity - Wikidata - wikimedia - TriplyDB

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

http://www.wikidata.org/entity/Q28743309

about

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza viruses Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.Viral vector-based influenza vaccines.Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines Novel viral vectored vaccines for the prevention of influenza.Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.New Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus.A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans.Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses Development of a universal CTL-based vaccine for influenza.Exploration of the BF2*15 major histocompatibility complex class I binding motif and identification of cytotoxic T lymphocyte epitopes from the H5N1 influenza virus nucleoprotein in chickens.Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.Influenza Viral Vectors Expressing Two Kinds of HA Proteins as Bivalent Vaccine Against Highly Pathogenic Avian Influenza Viruses of Clade 2.3.4.4 H5 and H7N9.Avian Influenza A Virus Pandemic Preparedness and Vaccine Development

P2860

Q26783897-621B448E-E145-4D0B-A01D-7802106CCB7C Q26825532-90FC3B69-4271-4D31-84A1-D8B5F1397786 Q28392109-15E2E12D-77E0-4120-A7E1-A851752A4593 Q30207890-C222BE71-9379-4A4A-8F29-ED4447D8252C Q30209342-CFB33EBD-F70D-4550-A88C-A495F2BC9AAC Q30353786-807A7A01-88B4-4C16-B76D-850B20AEAB94 Q30357094-DFCE09E8-E49A-4079-A294-706FC9C83A0E Q30358935-D98EAD81-E570-42A9-A803-580F9472D1F0 Q30361079-1AFC0403-9B47-405D-A76F-E6B793506C3C Q30366666-64C40EDF-B13F-48CF-A75E-EB00EA578291 Q30390938-727BAB60-87DE-48B9-8F85-E79707220786 Q30408295-ED449F2B-F2B9-47A3-AE9D-DF124D9ACEB1 Q30418570-707973C9-E40A-4C72-9159-AECA60BFD577 Q30426730-52F6A55B-650F-4B59-A7AA-F608C737340E Q30535722-2A80AF9F-B763-49AA-85C9-5C009FD294D9 Q34506918-8B018C49-7D3A-4E49-8096-F1F6F4B1C9AF Q34548282-1010E3D5-915D-42C7-A44D-9590AAB7FB90 Q35078213-DAB68868-AEE7-483E-BE94-5BE4761D6C2B Q35474243-EF598905-52B5-4696-B767-769BF13C1EE2 Q35928588-5FA95C74-7D11-4714-B8F5-557374646AD7 Q37091569-A0205A99-753B-4175-8DA2-28D06DD365EF Q37093491-AB0985CA-E361-46B8-9AAA-F8E5C4FA8579 Q38075677-503B6E62-9ACC-4B56-A5A7-926DDCD5F2A2 Q38752281-2D1DBC02-0C35-4C8B-99BC-5E55949C94DE Q39248220-D536BB75-A522-4D45-8F17-C0DED91245E2 Q52620757-593BCDF1-954F-4F4F-838E-9C4D20710A33 Q53829188-68DC3EC1-22FF-43D4-AD8B-9B9FE516F383 Q56561344-6509F8A8-BF15-4812-979B-A5F61AAF400D

P2860

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

http://www.wikidata.org/entity/Q28743309

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Vectors based on modified vacc ...... ross-clade protective immunity

@ast

Vectors based on modified vacc ...... ross-clade protective immunity

@en

Vectors based on modified vacc ...... ross-clade protective immunity

@nl

type

label

Vectors based on modified vacc ...... ross-clade protective immunity

@ast

Vectors based on modified vacc ...... ross-clade protective immunity

@en

Vectors based on modified vacc ...... ross-clade protective immunity

@nl

prefLabel

Vectors based on modified vacc ...... ross-clade protective immunity

@ast

Vectors based on modified vacc ...... ross-clade protective immunity

@en

Vectors based on modified vacc ...... ross-clade protective immunity

@nl

P1433

Q28743309-67C0BAF4-B095-4BC3-9A61-2B31B339A689

P1476

Q28743309-9E277597-20E7-4BE1-B0C5-539CE97315FD

P2093

Q28743309-02FE9C2D-F18B-404D-94C5-9FEBD01765F5

Q28743309-355C981D-70BC-4F5C-9405-24DF902D8595

Q28743309-3758BDBA-6235-47B5-BD94-974175225667

Q28743309-468390CD-5496-4EF4-8A87-33A2A4CDB622

Q28743309-935E749D-A9A8-45B7-B46E-17B8939C9D00

Q28743309-A0AA28CB-9244-4115-A4A8-576032AFA53A

Q28743309-C5F19073-A3DD-4508-A9DA-0B54DD4BE022

Q28743309-C6281D43-3E4A-4DD8-A333-433099B25E08

Q28743309-E966490D-13B3-46DC-96F3-62A76D48E90D

Q28743309-F6D8D17A-3538-4BAD-A3E2-ABA4DBACEDF2

P2860

Q28743309-267F6362-9E60-43B5-AAB6-1CB8BF1BCDD7

Q28743309-2C78C390-7BF6-414B-83C3-E899E880CCB4

Q28743309-2FECF99E-59C4-4FE2-9345-FFB595BC98C9

Q28743309-328EC4DE-8381-42F6-B14C-2E4294567C07

Q28743309-394368D4-A0B1-4B37-A25A-F97F6C40F3E6

Q28743309-3D04E40E-C445-4ED6-8C39-2728005F0192

Q28743309-4CB52A59-8C48-4F96-B97A-8F0C6F14FE27

Q28743309-4DFA27D1-A9FF-4449-A20D-75586A6CBCD8

Q28743309-4EDCF87E-0CBC-4E49-B5ED-19931B4246FF

Q28743309-5273B87B-3272-4477-AD5E-02D06D6FCF1A

P304

Q28743309-610DF04D-40BA-499F-8EDF-702FAA7FDF34

P31

Q28743309-1DA3C8C9-0743-467A-ADDC-A415CD4B7C53

P3181

Q28743309-9B1B8855-0459-47C4-BF9A-DEBF11F46A9D

P356

Q28743309-C73E38EF-E98C-43C5-A1EE-FE7AE070C94C

P407

Q28743309-A0502364-36A4-4F1C-9079-D37501AE8689

P433

Q28743309-21B51F24-D323-41C2-B2B4-270050B62919

P478

Q28743309-72F54A2A-9479-4D19-A72D-A79F5F8D2444

P577

Q28743309-C6E0BE52-95C4-4821-BF56-D74DEDF66654

P5875

Q28743309-DCA26130-3076-41C2-9CE6-05F31BB6A256

P698

Q28743309-34F72E81-9382-4245-970A-DD1733FF652F

P932

Q28743309-CAC9F110-207D-4100-895E-6F93F07209AB

P3181

P356

JOURNAL.PONE.0016247

P1433

P1476

Vectors based on modified vacc ...... ross-clade protective immunity

@en

P2093

Annett Hessel

http://www.w3.org/2001/XMLSchema#string

Brian A Crowe

http://www.w3.org/2001/XMLSchema#string

Falko G Falkner

http://www.w3.org/2001/XMLSchema#string

Georg W Holzer

http://www.w3.org/2001/XMLSchema#string

Hartmut J Ehrlich

http://www.w3.org/2001/XMLSchema#string

Helga Savidis-Dacho

http://www.w3.org/2001/XMLSchema#string

Klaus K Orlinger

http://www.w3.org/2001/XMLSchema#string

Marie-Luise Zips

http://www.w3.org/2001/XMLSchema#string

Michael Schwendinger

http://www.w3.org/2001/XMLSchema#string

P Noel Barrett

http://www.w3.org/2001/XMLSchema#string

P2860

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

Antibody recognition of a highly conserved influenza virus epitope

Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression

X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations

Antigenic cross-reactivity among H5N1 viruses.

Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.

P304

e16247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2519919

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0016247

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49800626

http://www.w3.org/2001/XMLSchema#string

P698

21283631

http://www.w3.org/2001/XMLSchema#string

P932

3026016

http://www.w3.org/2001/XMLSchema#string